Stay updated with breaking news from Beta Bionics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Today, the U.S. Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years...
The FDA announced today that it cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software.
The FDA has cleared a next-generation insulin pump and software combination that provides greater automation than current "artificial pancreas" systems.
System does away with need for carb counting
The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for persons 6 years of age and older with type 1 diabetes.